Chair, Reimbursement Group, Digital Health,
Asia Pacific Medical Association Ltd.
Regional Director, Health Economics & Reimbursement Asia Pacific,
Arif Fahim is part of Abbott’s Asia Pacific Regional Leadership team for the Medical Devices Division and holds overall functional responsibilities for the Health Economics & Reimbursement (HE&R) capability across business portfolios of Cardiac Rhythm Management (CRM), Electrophysiology, Heart Failure, Vascular, Structural Heart, and Neuromodulation. In addition, Arif also leads the HE&R global taskforce on Early Value Assessment at Abbott.
He has extensive experience in driving commercial and cross-functional partnerships, implementing innovative out-of-the-box approaches to market access, providing industry thought leadership, and driving multi-country, regional and global projects. Arif along with his team across the APAC region, have successfully negotiated numerous market access/entry agreements/premium requests with Governments and commercial health insurers. In his current and past roles, he has worked closely with healthcare payers and HTA agencies, developed value-based solutions for medical devices procurement/adoption, built new business models and market intelligence based support systems, and forged cross industry partnerships.
Arif currently Chairs APACMED’s Digital Health Reimbursement Committee and is an active member of the Market Access WG. Previously, he served as Vice Chair of the India WG and Chair of the Health Economics, Pricing and Reimbursement Sub-group at AdvaMed. Arif has attended Executive education at INSEAD and Yale School of Management, trained in HTA and Health Economics, including advance methods in cost effectiveness analysis and outcomes measurement, from the Centre of Health Economics, University of York, UK, and is an academic awardee and Masters’ Degree holder in Marketing and Strategy from the University of Durham, UK.